Skip to content Skip to navigation
University of Warwick
  • Study
  • |
  • Research
  • |
  • Business
  • |
  • Alumni
  • |
  • News
  • |
  • About

University of Warwick
Publications service & WRAP

Highlight your research

  • WRAP
    • Home
    • Search WRAP
    • Browse by Warwick Author
    • Browse WRAP by Year
    • Browse WRAP by Subject
    • Browse WRAP by Department
    • Browse WRAP by Funder
    • Browse Theses by Department
  • Publications Service
    • Home
    • Search Publications Service
    • Browse by Warwick Author
    • Browse Publications service by Year
    • Browse Publications service by Subject
    • Browse Publications service by Department
    • Browse Publications service by Funder
  • Statistics
  • Help & Advice
University of Warwick

The Library

  • Login

Adiponectin is a candidate marker of metabolic syndrome in obese children and adolescents

Tools
- Tools
+ Tools

Gilardini, Luisa, McTernan, P. G. (Philip G.), Girola, Andrea, da Silva, Nancy F., Alberti, Luisella, Kumar, Sudhesh and Invitti, Cecilia. (2006) Adiponectin is a candidate marker of metabolic syndrome in obese children and adolescents. ATHEROSCLEROSIS, 189 (2). pp. 401-407. ISSN 0021-9150

Full text not available from this repository.
Official URL: http://dx.doi.org/10.1016/j.atherosclerosis.2005.1...

Abstract

The aim of this study was to compare the use of several biomarkers to identify obese children and adolescents with increased metabolic risk. One hundred sixty-two Caucasian obese children and adolescents (41% males, 9-18 years old) referred to the Istituto Auxologico Italiano between 2003 and 2004 underwent an oral glucose tolerance test. Circulating levels of adiponectin (AD), plasminogen activator inhibitor I (PAI-1), interleukin 18 (IL-18), C-reactive protein (CRP), fibrinogen, uric acid, lipids and insulin were measured. Twenty five percent of obese children had the MS defined using World Health Organization-derived child specific criteria. MS subjects had significantly lower AD (p < 0.01) and higher log-PAI-I (p < 0.001), uric acid (p < 0.0001), and IL-18 (p < 0.001). Subjects with AD levels <= median value had a significantly increased risk of having the MS (p < 0.0001), as did subjects with uric acid and PAI-1 levels greater than the median. There was no increased risk with elevated IL-18, CRP, or fibrinogen. Hypoadiponectmemia was independently associated with the MS risk (p < 0.0001). In conclusion in obese children and adolescents AD is the best predictor of MS and thus of higher cardiovascular disease risk. (c) 2005 Elsevier Ireland Ltd. All rights reserved.

Item Type: Journal Article
Subjects: R Medicine > RC Internal medicine
Journal or Publication Title: ATHEROSCLEROSIS
Publisher: ELSEVIER IRELAND LTD
ISSN: 0021-9150
Date: December 2006
Volume: 189
Number: 2
Number of Pages: 7
Page Range: pp. 401-407
Identification Number: 10.1016/j.atherosclerosis.2005.12.021
Publication Status: Published
URI: http://wrap.warwick.ac.uk/id/eprint/32764

Data sourced from Thomson Reuters' Web of Knowledge

Request changes to a record

Actions (login required)

View Item View Item
twitter

Email us: publications@warwick.ac.uk
Contact Details
About Us